The Valley Desk

NCT03194867 · Interventional trial

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Overall registry status Completed

Phase 1 · Phase 2

Conditions Plasma Cell Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov